Breaking News Instant updates and real-time market news.

TLRY

Tilray

$77.14

-6.17 (-7.41%)

, CGC

Canopy Growth

$43.54

0.77 (1.80%)

08:45
01/22/19
01/22
08:45
01/22/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Tilray (TLRY) 95.14% +37.43, Canopy Growth (CGC) 27.55% +1.66, Direxion Energy Bull 3x (ERX) 3.82% +0.69, Sirius XM (SIRI) 16.11% +0.67, J C Penney (JCP) 14.86% +0.62, Direxion Junior Gold (JDST) 14.22% +0.46, Overstock com (OSTK) 6.76% +0.44, Ziopharm (ZIOP) 12.00% +0.43, Chesapeake (CHK) 1.28% +0.38, and Japanese Yen Trust (FXY) 2.19% +0.34.

TLRY

Tilray

$77.14

-6.17 (-7.41%)

CGC

Canopy Growth

$43.54

0.77 (1.80%)

SIRI

Sirius XM

$6.06

0.005 (0.08%)

JCP

J.C. Penney

$1.34

-0.005 (-0.37%)

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$53.69

4.29 (8.68%)

OSTK

Overstock.com

$15.20

1.59 (11.68%)

ZIOP

Ziopharm

$2.27

-0.21 (-8.47%)

CHK

Chesapeake

$2.98

0.085 (2.94%)

  • 18

    Feb

TLRY Tilray
$77.14

-6.17 (-7.41%)

01/16/19
PIPR
01/16/19
NO CHANGE
Target $90
PIPR
Overweight
Piper confident in Tilray strategy after management meeting
After meeting with management at the ICR conference, Piper Jaffray analyst Michael Lavery remains confident in Tilray's long-term strategy. Global regulatory momentum favoring legalization of medical and recreational cannabis products is continuing, and Tilray looks well positioned from a brand perspective with its latest partnership with Authentic Brands Group, which includes many readily recognizable brands, Lavery tells investors in a research note. The analyst expects strong industry growth in the long-term and we believes Tilray is well positioned to be one of several likely winners. He keeps an Overweight rating on the shares.
12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.
01/09/19
PIPR
01/09/19
INITIATION
Target $90
PIPR
Overweight
Tilray initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery initiated coverage of Tilray with an Overweight rating and $90 price target. The analyst expects "strong" industry growth long-term, and believes Tilray is well positioned to be one of several likely winners given its relationships in medical, in the U.S., and in beverages. Lavery consider the company's initial public offering lock-up expiry to be a near-term risk, especially with 77% insider ownership, but his 12-month Overweight view is based on its fundamental outlook. He pegs Tilray's market opportunity at $15B-$50B in the near-term, and potentially $250B-$500B over the longer term.
01/09/19
PIPR
01/09/19
INITIATION
PIPR
Overweight
Piper Jaffray rolls out bullish research coverage on Canopy Growth, Tilray
Piper Jaffray analyst Michael Lavery initiated coverage of Canopy Growth (CGC) and Tilray (TLRY) with Overweight ratings and price targets of $40 and $90, respectively. The analyst believes the global Cannabis market has the potential to reach $250B-$500B over the long term and $15B-$50B in the near term. The industry's long-term growth opportunities are significant, both from transitioning illicit trade to legal sales and from transitioning sales in health and wellness categories to cannabidiol-infused products, Lavery tells investors in a research note. The analyst expects recreational use to source from illicit trade and alcohol, medical use to source from other medical treatments, and non-psychoactive CBD-infused cannabis products to source users from food, beverage, and personal care categories. Over 25 countries have legal marijuana use today, he points out. Lavery believes federal legalization in the U.S. could potentially come in the next five years. Further, the analyst expects capital flow into the sector will likely continue.
CGC Canopy Growth
$43.54

0.77 (1.80%)

01/18/19
CIBC
01/18/19
INITIATION
CIBC
Neutral
Aphria initiated with a Neutral at CIBC
CIBC analyst John Zamparo initiated Aphria (APHA) with a Neutral rating and C$10 price target. He expects cannabis to follow the course of other newborn industries, where investors rush to pour capital into the sector and then very few companies live up to their lofty expectations while the industries develop. The debate over the value of Aphria's international assets and corporate governance concerns have obscured the value of the company's quality domestic assets, but concerns about corporate governance and capital allocation are not without some validity, Zamparo tells investors. He also initiated coverage on two other cannabis stocks, Canopy Growth (CGC) and Cronos Group (CRON), both with Outperformer ratings this morning, citing his favorable view of their management teams.
01/18/19
CIBC
01/18/19
INITIATION
CIBC
Outperformer
Canopy Growth initiated with an Outperformer at CIBC
CIBC analyst John Zamparo initiated Canopy Growth (CGC) with an Outperformer rating and C$65 price target. He expects cannabis to follow the course of other newborn industries, where investors rush to pour capital into the sector and then very few companies live up to their lofty expectations while the industries develop. However, he believes Canopy, and Cronos (CRON), are likely to be two of the winners that come to dominate the global market. His investment preference points him toward the Canopy ecosystem, both Growth and Rivers, mostly due to its best-in-class management, Zamparo tells investors.
01/17/19
JEFF
01/17/19
NO CHANGE
Target $258
JEFF
Buy
Constellation Brands remains top pick after beer update at Jefferies
Constellation Brands (STZ) "confidently outlined the attractive growth story still ahead" at its beer segment update in Chicago, Jefferies analyst Kevin Grundy tells investors in a research note. The analyst believes the positive tone on the company's "key value driver," which presents over 70% of its EBITDA, should "quell some concerns that have contributed to recent dislocation in the stock." Constellation's beer business remains healthy while the Canopy Growth (CGC) stake in now a free call option, writes Grundy. The stock remains his top pick with a Buy rating and $258 price target.
01/18/19
CIBC
01/18/19
INITIATION
CIBC
Outperformer
Cronos Group initiated with an Outperformer at CIBC
CIBC analyst John Zamparo initiated Cronos Group (CRON) with an Outperformer rating and C$22 price target. He expects cannabis to follow the course of other newborn industries, where investors rush to pour capital into the sector and then very few companies live up to their lofty expectations while the industries develop. However, he believes Cronos, and Canopy Growth (CGC), are likely to be two of the winners that come to dominate the global market. He believes the actions and visions of Cronos' management team stands above the rest of the field, Zamparo tells investors.
SIRI Sirius XM
$6.06

0.005 (0.08%)

01/02/19
JPMS
01/02/19
UPGRADE
Target $7
JPMS
Overweight
Sirius XM upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Sebastiano Petti upgraded Sirius XM Holdings (SIRI) to Overweight ahead of the Pandora Media (P) acquisition close. The analyst raised his price target for the shares to $7 from $6.
01/02/19
JPMS
01/02/19
UPGRADE
Target $7
JPMS
Overweight
JPMorgan upgrades Sirius XM to Overweight after 25% pullback
JPMorgan analyst Sebastiano Petti upgraded Sirius XM Holdings (SIRI) to Overweight from Neutral ahead of the close of the company's Pandora Media (P) acquisition. The analyst raised his price target for the shares to $7 from $6. Sirius XM shares are attractively following the 25% pullback from the 2018 highs, Petti tells investors in a research note. He looks for the company's "strong results year-to-date to persist" in Q4 and 2019 and believes the Pandora acquisition "can augment growth in new and existing segments."
01/02/19
01/02/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bausch Health (BHC) upgraded to Overweight from Neutral at Piper Jaffray with analyst David Amsellem saying while he's been "unrelentingly negative" on the company for years, it is time to "turn the page following a closer look at the business." 2. Crocs (CROX) and Shoe Carnival (SCVL) were upgraded to Positive from Neutral at Susquehanna. 3. Stryker (SYK) upgraded to Outperform from In Line at Evercore ISI. 4. CBS (CBS) upgraded to Overweight from Equal Weight at Stephens with analyst Kyle Evans saying he believes investor sentiment is poised to improve on the name in 2019 and that the company can continue to post solid results driven by underlying unit growth and stronger pricing. 5. Sirius XM (SIRI) upgraded to Overweight from Neutral at JPMorgan with analyst Sebastiano Petti saying Sirius XM shares are attractively following the 25% pullback from the 2018 highs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/07/19
FBNS
01/07/19
NO CHANGE
FBNS
Outperform
Liberty SiriusXM named top pick for 2019 at FBN Securities
FBN Securities analyst Robert Routh says Liberty SiriusXM (LSXMA, LSXMK) is his firm's top pick for 2019. The recent decline in Sirius XM's (SIRI) share price and the resulting impact on Liberty SiriusXM "should easily reverse this year," Routh tells investors in a research note. Further, the analyst believes the "unreasonable" 49.91% discount currently ascribed to Liberty SiriusXM relative to its intrinsic value should close "in the not too distant future." In addition, he thinks both Liberty SiriusXM and SiriusXM's share repurchase activity will continue and possibly accelerate in 2019. Routh also views the latter's 2019 guidance as conservative. The analyst has an Outperform rating on Liberty SiriusXM.
JCP J.C. Penney
$1.34

-0.005 (-0.37%)

11/16/18
ARGS
11/16/18
DOWNGRADE
ARGS
Sell
J.C. Penney downgraded to Sell from Hold at Argus
Argus analyst John Eade downgraded J.C. Penney to Sell, anticipating continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. The analyst states that while J.C Penney has made efforts to "restructure its merchandise assortment, close underperforming stores, and bolster its Omnichannel business, its operating results continue to deteriorate." Eade cites the company's margin deterioration coming from store closings, poor inventory management, and "steep discounting" intended to clear excess inventory. The analyst also sees J.C. Penney operating against "intense" competition from a wide range of retailers and suffering from weak mall traffic, while also facing a very expensive "arms race" to improve e-commerce capabilities.
11/16/18
11/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Home Depot (HD) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying peak growth has passed. 2. J.C. Penney (JCP) downgraded to Sell from Hold at Argus with analyst John Eade saying he anticipates continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. 3. Nvidia (NVDA) was downgraded to Neutral from Buy at B. Riley FBR and to Buy from Conviction Buy at Goldman Sachs. 4. Michael Kors (KORS) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel saying he is "concerned" that ongoing challenges with inventory management and replenishment at the company's namesake brand and softness within fashion watches will weigh on top-line trends and potentially margins, just as management begins the integration of Versace. 5. TSMC (TSM) was downgraded to Equal Weight from Overweight at Morgan Stanley while UMC (UMC) was downgraded to Underweight from Equal Weight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/19
FBCO
01/09/19
NO CHANGE
FBCO
J.C. Penney looks best positioned to gain share from Sears, says Credit Suisse
Looking at potential near-term same-store sales lift Softlines Retail peers could see from share gains based on proximity to Sears (SHLD) stores amid a possible liquidation, Credit Suisse analyst Michael Binetti says J.C. Penney (JCP) and Burlington Stores (BURL) seem best positioned to gain share in 2019 due to close proximity. And while J.C. Penney looks best positioned to gain share from Sears, the analyst thinks the recent stock run-up is "a short-term bounce." Binetti does not see this as sustainable customer acquisition for J.C. Penney given the increased risk of closing destabilized malls, limited visibility to an improved merchandise strategy, and leverage constraints to growth investing. Overall, the analyst believes that while there may be some near-term share benefit, a Sears liquidation could be a bigger tipping point that will accelerate closures of already weakening U.S. C&D malls.
01/16/19
FBCO
01/16/19
NO CHANGE
Target $50
FBCO
Neutral
Nordstrom price target lowered to $50 from $55 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Nordstrom (JWN) to $50 from $55 on weak full-price holiday adding to already clearance filled January. With Nordstrom adding to industry markdown issues, the analyst sees negative reads for J.C. Penney (JCP), Kohl's (KSS), Gap (GPS), but positive for Burlington Stores (BURL), Ross Stores (ROST), and TJX (TJX). Binetti reiterates a Neutral rating on Nordstrom shares.
JDST Direxion Daily Junior Gold Miners Index Bear 3x Shares
$53.69

4.29 (8.68%)

OSTK Overstock.com
$15.20

1.59 (11.68%)

10/04/18
GARP
10/04/18
UPGRADE
GARP
Buy
Overstock.com upgraded to Buy from Neutral at Garp Research
10/10/18
LOOP
10/10/18
NO CHANGE
Target $59
LOOP
Buy
Loop Capital 'optimistic' on Aaron's profitability ahead of Q3
Loop Capital analyst Anthony Chukumba kept his Buy rating and $59 price target on Aaron's (AAN) ahead of its Q3 earnings, saying his EPS estimate is 4c ahead of consensus based on his "optimistic profitability expectations". The analyst expects investors to focus on the company's "core business same store revenue growth and profitability, Progressive active door and invoice volume per active door growth, and Progressive's recently announced partnership with Overstock.com (OSTK). Chukumba further states that the implied 14.7-times valuation multiple of his expected FY19 earnings reflects "Progressive's substantial 'white space' opportunity and expectation of sequential improvement in the Aaron's Business".
12/18/18
DADA
12/18/18
NO CHANGE
Target $58
DADA
Buy
Overstock.com price target lowered to $58 from $112 at DA Davidson
DA Davidson analyst Tom Forte slashed his price target on Overstock.com to $58 after the company's disclosure to investors that it was unable to finalize its GSR Ventures transaction by its mid-December target yesterday, pushing that deadline to February of next year. The analyst notes that investors responded to this management stumble by sending the stock price down over 20% from what he sees as "already depressed levels". Forte still keeps his Buy rating on Overstock.com, but states that his new valuation methodology is based on more of a "crawl, walk, run approach", even though he still values the company's 80% tZero holdings at a $1B valuation that equates to $27 per share and its retail business at 31 per share.
12/21/18
DADA
12/21/18
NO CHANGE
Target $58
DADA
Buy
DA Davidson sees encouraging signs for Overstock despite GSR disappointment
DA Davidson analyst Tom Forte said while he recognizes the recent disappointment regarding Overstock's inability to close its transactions with GSR Ventures, he is also seeing encouraging signs for the company's blockchain-related investments. "Lost in the disappointment of Monday" was the announcement that GSR Ventures and tZERO intend to work together to tokenize cobalt, which he sees as one example of potentially many regarding its ability to play an instrumental role in the creation and trading of tokens, Forte tells investors. He reiterates a Buy rating and $58 price target on Overstock shares and recommends purchasing at current levels, noting that his target includes a $31 per share valuation for its legacy home e-commerce business and $27 for its Medici Ventures portfolio of 19 blockchain companies, most of that being attributable to tZERO.
ZIOP Ziopharm
$2.27

-0.21 (-8.47%)

06/19/18
HCWC
06/19/18
NO CHANGE
Target $5.5
HCWC
Buy
Ziopharm selloff brings buying opportunity, says H.C. Wainwright
The clinical hold placed on Ziopharm's third generation point-of-care CAR-T program is unlikely to bring a significant delay, H.C. Wainwright analyst Swayampakula Ramakanth tells investors in a research note. The analyst views yesterday's 18% share pullback as a buying opportunity and reiterates a Buy rating on Ziopharm with a $5.50 price target. He notes that neither of the Ziopharm's clinical programs on Ad-RTS-hIL-12 or second generation CD19 and CD33 CAR-Ts has been affected by the clinical hold. The clinical hold is more akin to the FDA putting a "pause" on the investigational new drug application review process while the company prepares the response, Ramakanth argues.
11/15/18
11/15/18
UPGRADE
Target $5

Outperform
Ziopharm upgraded to Outperform at Raymond James
As previously reported, Raymond James analyst Reni Benjamin upgraded Ziopharm to Outperform from Market Perform, with a $5 price target. The analyst notes that the company provided an update on its cell and gene therapy programs in a recent conference call, saying it has severed its relationship with Intrexon, eliminating $157M million in preferred stock and significantly simplifying its corporate structure. Additionally, Ziopharm said that in conjunction with Steven Rosenberg and the NCI, it plans to utilize the Sleeping Beauty neoantigen platform to generate patient specific TCRs, with the filing of an IND expected by year end 2018/early 2019, he pointed out, adding that a cash infusion of $50M from long-term investors should extend the company's cash runway to Q2 of 2020.
11/15/18
RAJA
11/15/18
UPGRADE
RAJA
Outperform
Ziopharm upgraded to Outperform from Market Perform at Raymond James
06/18/18
JPMS
06/18/18
DOWNGRADE
JPMS
Underweight
Ziopharm downgraded to Underweight from Neutral at JPMorgan
CHK Chesapeake
$2.98

0.085 (2.94%)

01/04/19
BOFA
01/04/19
DOWNGRADE
Target $3.5
BOFA
Underperform
Chesapeake downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill Lynch analysts led by Doug Leggate downgraded a number of U.S. Oil and Gas stocks, stating that he prefers "discipline over growth" among large caps. Leggate and the team acknowledge a recovery in oil prices could lead to material upside, but views volatility as the biggest challenge as too many stocks are competing for shrinking investor dollars. He sees gas names remaining challenged by the falling incremental cost for U.S. natural gas and downgraded Chesapeake to Underperform from Neutral given the headwinds he sees for gas weighted E&P names. Leggate and the team lowered their price target for Chesapeake to $3.50 from $6.00.
01/04/19
01/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Skyworks (SWKS) downgraded to Neutral from Buy at Nomura Instinet with analyst Krysten Sciacca saying after Apple's (AAPL) profit warning, she believes growth headwinds from macro and trade uncertainty, as well as weak unit demand at the company's largest customers, will persist in 2019. 2. Snap (SNAP) downgraded to Neutral from Buy at Goldman Sachs with analyst Heath Terry saying he believes Snap's sequential user declines are likely to continue in Q4. 3. Fortinet (FTNT) double downgraded to Sell from Buy at Goldman Sachs with analyst Gabriela Borges saying the drivers of Fortinet's share gain and margin expansion are now better understood, with consensus 2019 estimates having been revised up over the past 12 months. 4. eBay (EBAY) downgraded to Neutral from Buy at Goldman Sachs with analyst Heath Terry saying he sees better opportunities with other names in Internet given uncertainty around eBay's growth and margin expansion, specifically the company's ability to deliver low-to-mid single digit growth on reduced ad spend. 5. Halcon Resources (HK), Chesapeake (CHK), and Southwestern Energy (SWN) were downgraded to Underperform from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
IMPC
01/10/19
NO CHANGE
Target $3
IMPC
In-Line
Chesapeake price target lowered to $3 from $5 at Imperial Capital
Imperial Capital analyst Jason Wangler lowered his price target for Chesapeake Energy to $3 and keeps an In-Line rating on the shares following the company's operational update. Chesapeake's Q4 production was strong on the back of active/successful Powder River Basin and Eagle Ford operations, Wangler tells investors in a research note. Further, he says the company's 2019 activity and efficiency is expected to reduce capital expenditures.
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Underweight
Chesapeake downgraded to Underweight from Overweight at Capital One

TODAY'S FREE FLY STORIES

21:25
03/25/19
03/25
21:25
03/25/19
21:25
General news
Fed's Rosengren warned that U.S. Q1 growth is likely to be weak »

Fed's Rosengren…

BBBY

Bed Bath & Beyond

$13.87

0.17 (1.24%)

20:44
03/25/19
03/25
20:44
03/25/19
20:44
Periodicals
Activist firms seek to replace Bed Bath & Beyond board, CEO, WSJ says »

Activist funds -Legion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

RTN

Raytheon

$180.58

-0.82 (-0.45%)

, BA

Boeing

$370.52

8.37 (2.31%)

20:36
03/25/19
03/25
20:36
03/25/19
20:36
Hot Stocks
Raytheon kill vehicle hits ICBM target in first dual-salvo test »

For the first time, the…

RTN

Raytheon

$180.58

-0.82 (-0.45%)

BA

Boeing

$370.52

8.37 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

20:35
03/25/19
03/25
20:35
03/25/19
20:35
General news
The "Summary of Opinions" from the BoJ's March meeting »

The "Summary of…

WHD

Cactus

$36.03

1.225 (3.52%)

20:27
03/25/19
03/25
20:27
03/25/19
20:27
Hot Stocks
Cactus VP of Operations sells 229K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$56.67

-0.065 (-0.11%)

, MKC

McCormick

$143.88

1.58 (1.11%)

20:25
03/25/19
03/25
20:25
03/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$56.67

-0.065 (-0.11%)

MKC

McCormick

$143.88

1.58 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

CRTO

Criteo

$21.99

-3.4 (-13.39%)

20:19
03/25/19
03/25
20:19
03/25/19
20:19
Downgrade
Criteo rating change at KeyBanc »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

20:02
03/25/19
03/25
20:02
03/25/19
20:02
Periodicals
Samsung sees weaker environment for display, memory in Q1, Bloomberg says »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$370.52

8.37 (2.31%)

19:51
03/25/19
03/25
19:51
03/25/19
19:51
Hot Stocks
U.S. MDA and Boeing Complete Historic Missile Defense Test »

The U.S. Missile Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MCD

McDonald's

$185.66

-1.11 (-0.59%)

19:49
03/25/19
03/25
19:49
03/25/19
19:49
Periodicals
McDonald's purchase price of Dynamic Yield above $300M, Bloomberg says »

The purchase of Dynamic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

19:32
03/25/19
03/25
19:32
03/25/19
19:32
Periodicals
Breaking Periodicals news story on Samsung »

Samsung sees Q1 below…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWR

American States Water

$71.51

0.505 (0.71%)

19:22
03/25/19
03/25
19:22
03/25/19
19:22
Hot Stocks
American States Water CEO sells 12.4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$56.35

-1.38 (-2.39%)

19:10
03/25/19
03/25
19:10
03/25/19
19:10
Hot Stocks
Methanex confirms receipt of director nominees notice from M&G »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

, SAEX

SAExploration

$4.03

0.13 (3.33%)

18:55
03/25/19
03/25
18:55
03/25/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

DOWN AFTER EARNINGS:…

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

SAEX

SAExploration

$4.03

0.13 (3.33%)

IQ

iQIYI

$24.01

-0.86 (-3.46%)

MYOK

MyoKardia

$51.87

-2.44 (-4.49%)

CTMX

CytomX Therapeutics

$10.76

0.33 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 21

    May

  • 27

    Mar

HPQ

HP Inc.

$18.97

-0.4 (-2.07%)

18:48
03/25/19
03/25
18:48
03/25/19
18:48
Periodicals
HP lawyer tells court Autonomy's Lynch inflated sales data, Reuters says »

A lawyer for HP told a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

PEGA

Pegasystems

$63.61

-0.27 (-0.42%)

18:45
03/25/19
03/25
18:45
03/25/19
18:45
Hot Stocks
Pegasystems CEO: We are massively changing our marketing strategy »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SMTC

Semtech

$52.59

-0.38 (-0.72%)

18:32
03/25/19
03/25
18:32
03/25/19
18:32
Hot Stocks
Semtech CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TMO

Thermo Fisher

$268.89

5.015 (1.90%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Hot Stocks
Thermo Fisher CEO: We have a very disciplined M&A process »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Periodicals
Parliament forces votes on Brexit plan options, Bloomberg reports »

Lawmakers of U.K.…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.99

-0.56 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$185.66

-1.11 (-0.59%)

18:23
03/25/19
03/25
18:23
03/25/19
18:23
Hot Stocks
McDonald's to acquire Dynamic Yield, terms not stated »

McDonald's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

BA

Boeing

$370.52

8.37 (2.31%)

18:22
03/25/19
03/25
18:22
03/25/19
18:22
Periodicals
Boeing software fix to prevent repeated activiation of MCAS, Reuters says »

A Boeing software repair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ACHC

Acadia

$29.47

-0.59 (-1.96%)

17:58
03/25/19
03/25
17:58
03/25/19
17:58
Hot Stocks
Acadia says President Brett Turner leaving by mutual agreement »

Brent Turner, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.78

-2.33 (-1.22%)

17:41
03/25/19
03/25
17:41
03/25/19
17:41
Recommendations
Apple analyst commentary at Piper Jaffray »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

ZFGN

Zafgen

$2.70

-0.15 (-5.26%)

17:38
03/25/19
03/25
17:38
03/25/19
17:38
Hot Stocks
Armistice Capital reports 5.6% passive stake in Zafgen »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$268.56

0.27 (0.10%)

17:36
03/25/19
03/25
17:36
03/25/19
17:36
Hot Stocks
Northrop Grumman awarded $245.05M Navy contract modification »

Northrop Grumman has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.